GENOMICS AND PROTEOMICS METHODS AND THEIR VALUE IN BREAST CANCER DIAGNOSIS
PDF
Cite
Share
Request
Review
P: 47-52
April 2010

GENOMICS AND PROTEOMICS METHODS AND THEIR VALUE IN BREAST CANCER DIAGNOSIS

Eur J Breast Health 2010;6(2):47-52
1. Genel Cerrahi, Ankara Onkoloji Hastanesi, Ankara
No information available.
No information available
Received Date: 13.07.2009
Accepted Date: 28.08.2009
PDF
Cite
Share
Request

ABSTRACT

Genomics and proteomics are newly developing fields and becoming widely used in cancer research especially in cancer diagnosis. The aim is to review the role of genomics and proteomics to discover new breast cancer biomarkers for diagnosis with higher sensitivity and specificity. Studies reporting on potential biomarkers in breast cancer were included in this review. In the future, platforms in genomics and proteomics will be used for the discovery of tumor specific genes and related proteins, which will lead to development of novel therapeutic targets leading to patient specific therapies.

Keywords:
cancer, diagnosis, genomics, proteomics